The Pfizer Foundation* contributes to antibiotic resistance innovation prize

The prize fund for the Trinity Challenge on Antimicrobial Resistance was supported by the Pfizer Foundation. The ability of the Trinity Challenge to identify and support innovative solutions to global health threats depends on donations such as this one.

Given most of the current data available on antibiotic resistance is from high-income countries, funding needs to be secured to power potential solutions that could both tackle antibiotic resistance and help fill this data gap. For example, the Challenge has encouraged solutions that might develop new tools to capture community data; combine data sets in novel ways to increase understanding, or provide new ways to harness data to implement action and policy change.

The donation made by The Pfizer Foundation to the prize fund has increased the potential impact of the solutions teams that were awarded funding.

You can read more about the winners of the Trinity Challenge on Antimicrobial Resistance here.

Professor Marc Mendelson, Director, the Trinity Challenge, said: “Through this Challenge, we wanted to attract and support the best and brightest minds across sectors to share ideas on how to protect the power of antibiotics, particularly in lower- and middle-income countries who suffer the greatest impact from this growing threat. I am extremely pleased to have been able to work with The Pfizer Foundation on this Challenge, and that they have contributed to the prize funding that is now going to the most promising solutions for antibiotic resistance.”

Jenny Sia, The Pfizer Foundation, said: “AMR is a global public health issue that threatens to eliminate some our most powerful tools to combat disease. We, at The Pfizer Foundation, recognize the importance and urgency of finding and executing solutions to combat AMR and are proud to partner with this Challenge to support the teams seeking innovative ways to address AMR.”

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions